Phyto Chem (India) Ltd
Incorporated in 1989, Phyto Chem Ltd is in the manufacturing of pesticide formulations and real estate activities[1]
- Market Cap ₹ 10.1 Cr.
- Current Price ₹ 23.5
- High / Low ₹ 35.0 / 18.5
- Stock P/E
- Book Value ₹ 10.6
- Dividend Yield 0.00 %
- ROCE -1.57 %
- ROE -32.8 %
- Face Value ₹ 10.0
Pros
- Company's working capital requirements have reduced from 128 days to 94.2 days
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -27.2% over past five years.
- Company has a low return on equity of -29.1% over last 3 years.
- Company has high debtors of 660 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.92 | 21.77 | 44.45 | 58.90 | 59.11 | 44.22 | 44.49 | 23.12 | 26.76 | 14.75 | 14.08 | 9.07 | |
| 38.27 | 20.24 | 41.58 | 56.75 | 56.68 | 42.30 | 42.28 | 21.70 | 24.16 | 18.02 | 15.42 | 10.93 | |
| Operating Profit | 2.65 | 1.53 | 2.87 | 2.15 | 2.43 | 1.92 | 2.21 | 1.42 | 2.60 | -3.27 | -1.34 | -1.86 |
| OPM % | 6.48% | 7.03% | 6.46% | 3.65% | 4.11% | 4.34% | 4.97% | 6.14% | 9.72% | -22.17% | -9.52% | -20.51% |
| 0.12 | 0.68 | 0.27 | 1.55 | 0.98 | 1.38 | 0.80 | 1.29 | 0.16 | 2.32 | 2.47 | 1.83 | |
| Interest | 1.64 | 1.72 | 1.67 | 2.13 | 2.10 | 2.47 | 2.12 | 2.10 | 2.10 | 2.05 | 1.84 | 1.50 |
| Depreciation | 0.32 | 0.31 | 0.31 | 0.36 | 0.40 | 0.41 | 0.43 | 0.41 | 0.40 | 0.34 | 0.34 | 0.34 |
| Profit before tax | 0.81 | 0.18 | 1.16 | 1.21 | 0.91 | 0.42 | 0.46 | 0.20 | 0.26 | -3.34 | -1.05 | -1.87 |
| Tax % | 34.57% | 38.89% | 26.72% | 23.97% | 19.78% | -4.76% | -6.52% | -15.00% | 15.38% | -0.30% | -5.71% | -3.74% |
| 0.54 | 0.12 | 0.85 | 0.92 | 0.73 | 0.45 | 0.49 | 0.23 | 0.22 | -3.33 | -0.99 | -1.80 | |
| EPS in Rs | 1.26 | 0.28 | 1.98 | 2.14 | 1.70 | 1.05 | 1.14 | 0.53 | 0.51 | -7.74 | -2.30 | -4.19 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | -27% |
| 3 Years: | -30% |
| TTM: | -36% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -80% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 1% |
| 3 Years: | -13% |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -14% |
| 3 Years: | -29% |
| Last Year: | -33% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
| Reserves | 3.48 | 3.60 | 4.00 | 4.52 | 5.12 | 5.55 | 5.88 | 6.15 | 6.31 | 3.06 | 2.09 | 0.27 |
| 16.00 | 16.04 | 18.46 | 18.55 | 22.08 | 22.98 | 21.37 | 21.23 | 19.47 | 18.19 | 15.77 | 20.49 | |
| 11.92 | 5.63 | 15.24 | 30.31 | 41.46 | 34.87 | 13.91 | 6.78 | 9.94 | 6.16 | 5.72 | 2.99 | |
| Total Liabilities | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 | 28.05 |
| 3.68 | 3.50 | 3.25 | 4.10 | 4.18 | 4.67 | 3.43 | 3.13 | 2.75 | 2.74 | 2.39 | 2.07 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.09 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.32 | 0.32 | 0.24 | 0.25 | 0.12 | 0.11 | 0.16 | 0.17 | 0.07 | 0.08 | 0.05 | 0.05 |
| 31.70 | 25.75 | 38.51 | 53.24 | 68.21 | 62.92 | 41.87 | 35.16 | 37.20 | 28.89 | 25.44 | 25.93 | |
| Total Assets | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 | 28.05 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.13 | -0.34 | 1.53 | 0.76 | 1.95 | 1.49 | -0.71 | 3.41 | 1.42 | 3.41 | 1.77 | 0.91 | |
| 0.32 | 0.60 | 0.16 | 0.24 | 0.26 | -0.39 | 1.06 | 0.05 | 0.21 | -0.05 | 1.02 | 1.62 | |
| 1.79 | -0.48 | -1.76 | -1.02 | -2.19 | -1.10 | -0.40 | -3.45 | -1.70 | -3.26 | -2.91 | -2.56 | |
| Net Cash Flow | -0.02 | -0.23 | -0.06 | -0.01 | 0.02 | -0.01 | -0.05 | 0.01 | -0.07 | 0.10 | -0.12 | -0.02 |
| Free Cash Flow | -2.17 | -0.48 | 1.46 | -0.54 | 1.11 | 1.04 | 0.44 | 3.30 | 1.44 | 3.15 | 1.79 | 0.90 |
| CFO/OP | -70% | -18% | 67% | 55% | 88% | 77% | -33% | 238% | 56% | -104% | -137% | -45% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 155.83 | 247.97 | 212.84 | 234.37 | 306.89 | 360.30 | 182.87 | 317.01 | 275.66 | 388.26 | 369.41 | 659.58 |
| Inventory Days | 159.73 | 260.64 | 133.35 | 115.59 | 128.58 | 182.77 | 172.49 | 342.41 | 314.83 | 373.42 | 338.21 | 352.24 |
| Days Payable | 113.43 | 86.08 | 135.72 | 176.25 | 283.01 | 338.07 | 110.32 | 41.10 | 122.87 | 91.09 | 91.75 | 26.38 |
| Cash Conversion Cycle | 202.12 | 422.53 | 210.47 | 173.71 | 152.46 | 205.00 | 245.04 | 618.32 | 467.62 | 670.59 | 615.87 | 985.44 |
| Working Capital Days | 48.26 | 103.95 | 53.62 | 43.75 | 45.14 | 69.58 | 85.08 | 155.35 | 150.45 | 161.34 | 129.88 | 94.17 |
| ROCE % | 12.02% | 7.75% | 11.16% | 12.34% | 10.16% | 8.98% | 6.96% | 7.28% | 7.55% | -4.93% | 3.27% | -1.57% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Imported Raw Material Share of Total Consumption % |
|
|||||||||
| Number of Permanent Employees count |
||||||||||
| Pesticides Formulations Share of Total Turnover (MGT-9) % |
||||||||||
| Total Raw Material Consumption Kgs |
||||||||||
| Production Volume (Pesticides Formulations) Ltrs |
||||||||||
| Sales Volume (Pesticides Formulations) Ltrs |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Jul - Regulation 74(5) certificate confirmed dematerialization compliance for quarter ended 30 June 2026.
- Closure of Trading Window 30 Jun
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report for FY ended March 31, 2026; minor delays noted in results and RTA certificate filings.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 May - Copies of the newspaper advertisement pertaining Audited Financial Results of the Company for the Quarter and Year ended March 31, 2026. The advertisements were published …
-
Results-Financial Results For May 29Th 2026(Submission Of Audited Financial Results Of The Company For The Fourth
Quarter & Year Ended 31St March 2026
29 May - FY26 audited results approved; ₹6.22 crore claim filed before IRP of Siri Smelters.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
PCL operates in the Agrochemicals sector and is engaged in the manufacturing and marketing of Pesticides for the agriculture sector. Its products are marketed under proprietary brands through a dealer and distributor network in Telangana, Andhra Pradesh, Maharashtra, and Karnataka.
The company's operations are spread across two segments:
a) Pesticides Formulations
b) Real Estate Activities